|
2024
|
P/S
|
Pharmaceutical preparations; Medicines for human purposes; Medical reagent; Diagnostic agents, pr... |
|
|
P/S
|
Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agen... |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes;
medical reagent; diagnostic agents, p... |
|
|
Invention
|
Oral rifamycin sv compositions.
Oral pharmaceutical compositions containing rifamycin SV, or a p... |
|
|
Invention
|
Liquid delivery composition.
The invention provides a composition for use as a delivery vehicle ... |
|
|
Invention
|
17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors.
The presen... |
|
2023
|
P/S
|
Computer hardware used for the detection, identification and diagnosis of lesions and other patho... |
|
|
P/S
|
Pharmaceutical preparations; Diagnostic agents, preparations and substances for medical and surgi... |
|
2022
|
Invention
|
Oral rifamycin sv compositions. Oral pharmaceutical compositions containing rifamycin SV, or a ph... |
|
|
Invention
|
Solid oral composition containing dyes for use in endoscopic diagnosis.
Herein described are sol... |
|
|
Invention
|
17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors. The present... |
|
|
Invention
|
An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis.
The ... |
|
|
Invention
|
An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis. The p... |
|
|
P/S
|
Pharmaceutical and veterinary preparations for treatment within the fields of gastroenterology, d... |
|
2020
|
Invention
|
Oral antimicrobial pharmaceutical compositions.
The present invention relates to oral pharmaceut... |
|
|
Invention
|
Controlled release and taste masking oral pharmaceutical composition.
Controlled release and tas... |
|
|
P/S
|
Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagen... |
|
2019
|
Invention
|
Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucos... |
|
|
Invention
|
Solid composition for the oral administration of dyes and diagnostic use thereof.
The present ap... |
|
|
Invention
|
Method for treating intestinal diseases presenting at least one inflammatory component.
The pres... |
|
|
Invention
|
17alpha-monoesters of cortexolone for use in the treatment of tumors.
The present invention prov... |
|
|
Invention
|
Controlled release and taste masking oral pharmaceutical composition. Controlled release and tast... |
|
2018
|
Invention
|
Controlled release and taste masking oral pharmaceutical compositions.
The invention relates to ... |
|
|
Invention
|
Liquid delivery composition. The invention provides a composition for use as a delivery vehicle c... |
|
|
Invention
|
Solid delivery composition.
The present invention provides an innovative combination of biomater... |
|
|
Invention
|
Solid delivery composition. The present invention provides an innovative combination of biomateri... |
|
|
P/S
|
Diagnostic agents, preparations and substances for medical and surgical purposes, namely, the vis... |
|
|
P/S
|
Pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in g... |
|
|
P/S
|
Enema preparations; enema preparations for rectal administration containing a dye for cleansing; ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of travellers' diarrhea, diarrhea, diverticular dis... |
|
2017
|
Invention
|
Solid oral composition containing dyes.
The present invention relates to methods for improving t... |
|
|
Invention
|
Solid oral composition containing dyes. The present invention relates to methods for improving th... |
|
|
Invention
|
Cortexolone 17alpha-propionate for use in the treatment of skin wounds and/or atrophic skin disor... |
|
|
Invention
|
Controlled release and taste masking oral pharmaceutical compositions. The invention relates to t... |
|
2016
|
P/S
|
Enema preparations; enema preparations for rectal administration containing a dye for cleansing a... |
|
|
P/S
|
Diagnostic agents, preparations and substances for medical or surgical purposes; Diagnostic agent... |
|
|
P/S
|
Pharmaceutical preparations for use in gastroenterology, for colon and digestive system health an... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in the endoscopic diagnostic eva... |
|
2015
|
Invention
|
Cortexolone 17alpha-benzoate for use in the treatment of tumours. The present invention provides ... |
|
|
Invention
|
17α,21-diesters of cortexolone for use in the treatment of tumors. The present invention provides... |
|
|
P/S
|
Pharmaceutical products; dietetic substances adapted for medical use; lactic ferments for pharmac... |
|
2008
|
P/S
|
Pharmaceutical preparations for the treatment of the gastroenteric apparatus diseases. |
|
2006
|
P/S
|
Pharmaceutical preparations for the treatment of the gastroenteric diseases |
|
2005
|
P/S
|
Pharmaceutical and veterinary preparations such as tablets,
capsules, sugar-coated pills, granul... |
|
|
P/S
|
Pharmaceutical and veterinary preparations, namely anti-inflammatories, anti-infectives, antacids... |
|
|
P/S
|
Pharmaceutical and veterinary preparations such as tablets, capsules, sugar-coated pills, granule... |
|
2002
|
P/S
|
Pharmaceutical preparations for the treatment of gastroenteric diseases. |
|
|
P/S
|
Pharmaceutical preparations for treatment of disorders of the gastro-intestinal system. |
|
2001
|
P/S
|
Pharmaceuticals preparations for the treatment of the gastroenteric apparatus diseases |
|
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
